메뉴 건너뛰기




Volumn 63, Issue 1, 2004, Pages 1-7

A1 adenosine receptor antagonists, 3-aryl[1,2,4]triazino[4,3-a] benzimidazol-4-(10H)-ones (ATBIs) and N-alkyl and N-acyl-(7-substituted-2- phenylimidazo[1,2-a][1,3,5]triazin-4-yl)amines (ITAs): Different recognition of bovine and human binding sites

Author keywords

3 aryl 1,2,4 triazino 4,3 a benzimidazol 4 (10H) ones (ATBIs); Adenosine antagonists; Bovine and human A1 adenosine receptors; N alkyl and N acyl (7 substituted 2 phenylimidazo 1,2 a 1,3,5 triazin 4 yl)amines (ITAs); Structure activity relationships

Indexed keywords

3 ARYL 1,2,4 TRIAZINO 4,3 ALPHA BENZIMIDAZOL 4 10H ONE; ADENOSINE A1 RECEPTOR ANTAGONIST; ADENOSINE A2 RECEPTOR ANTAGONIST; ADENOSINE A3 RECEPTOR ANTAGONIST; AMINO ACID; N ACYL 7 SUBSTITUTED 2 PHENYLIMIDAZ 1,2 ALPHA 1,3,3 TRIAZIN 4 YL AMINE; N ALKYL 7 SUBSTITUTED 2 PHENYLIMIDAZO 1,2 ALPHA 1,3,3 TRIAZIN 4 YL AMINE; RADIOLIGAND; UNCLASSIFIED DRUG;

EID: 19944428678     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/ddr.10366     Document Type: Article
Times cited : (22)

References (24)
  • 4
    • 85047676554 scopus 로고
    • Adenosine and the anti-infarct effects of preconditioning
    • Downey JM, Liu GS, Thornton JD. 1993. Adenosine and the anti-infarct effects of preconditioning. Cardiovasc Res 27:3-8.
    • (1993) Cardiovasc Res , vol.27 , pp. 3-8
    • Downey, J.M.1    Liu, G.S.2    Thornton, J.D.3
  • 6
    • 33845216127 scopus 로고    scopus 로고
    • Adenosine and neuroprotection
    • Fredholm BB. 1997. Adenosine and neuroprotection. Int Rev Neurobiol 40:259-280.
    • (1997) Int Rev Neurobiol , vol.40 , pp. 259-280
    • Fredholm, B.B.1
  • 7
    • 0035209620 scopus 로고    scopus 로고
    • International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors
    • Fredholm BB, IJzerman AP, Jacobson KA, Klotz KN, Linden J. 2001. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53:527-552.
    • (2001) Pharmacol Rev , vol.53 , pp. 527-552
    • Fredholm, B.B.1    IJzerman, A.P.2    Jacobson, K.A.3    Klotz, K.N.4    Linden, J.5
  • 12
    • 0028169223 scopus 로고
    • 3 receptors: Pharmacological properties, species differences and receptor functions
    • 3 receptors: pharmacological properties, species differences and receptor functions. Trends Pharmacol Sci 15:298-306.
    • (1994) Trends Pharmacol Sci , vol.15 , pp. 298-306
    • Linden, J.1
  • 14
    • 0035271592 scopus 로고    scopus 로고
    • 1 adenosine receptors and their ligands: Overview and recent developments
    • 1 adenosine receptors and their ligands: overview and recent developments. Farmaco 56:77-80.
    • (2001) Farmaco , vol.56 , pp. 77-80
    • Möller, C.E.1
  • 18
    • 0031833150 scopus 로고    scopus 로고
    • Adenosine receptors: New opportunities for future drugs
    • Poulsen SA, Quinn RJ. 1998. Adenosine receptors: new opportunities for future drugs. Bioorg Med Chem 6:619-641.
    • (1998) Bioorg Med Chem , vol.6 , pp. 619-641
    • Poulsen, S.A.1    Quinn, R.J.2
  • 19
    • 0036973951 scopus 로고    scopus 로고
    • Adenosine receptors in the nervous system: Pathophysiological implications
    • Ribeiro JA, Sebastiao AM, de Mendonca A. 2003. Adenosine receptors in the nervous system: pathophysiological implications. Prog Neurobiol 68:377-392.
    • (2003) Prog Neurobiol , vol.68 , pp. 377-392
    • Ribeiro, J.A.1    Sebastiao, A.M.2    De Mendonca, A.3
  • 20
    • 0141540439 scopus 로고    scopus 로고
    • 1 receptor antagonist, FK838, increases renal excretion and maintains glomerular filtration rate in furosemide-resistant rats
    • 1 receptor antagonist, FK838, increases renal excretion and maintains glomerular filtration rate in furosemide-resistant rats. Br J Pharmacol 139:1383-1388.
    • (2003) Br J Pharmacol , vol.139 , pp. 1383-1388
    • Schnackenberg, C.G.1    Merz, E.2    Brooks, D.P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.